MoonLake Immunotherapeutics
MLTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001821586
In the last 90 days, MoonLake Immunotherapeutics insiders filed 0 open-market purchases and 6 sales; 172 institutions reported holding it in 13F filings for Q2 2026, worth $1.43B in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in MoonLake Immunotherapeutics as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- −4 vs. Q1 2022
- Shares held
- 36.5M
- +24.9M (+215.3%) vs. Q1 2022
- Total value
- $190.1M
- +$66.7M (+54.0%) vs. Q1 2022
- New holders
- 15
- 5 more added
- Sold out
- 19
- 2 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MLTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 172 | $1.43B |
| Q1 2026 | 147 | $1.17B |
| Q4 2025 | 130 | $742.9M |
| Q3 2025 | 133 | $268.4M |
| Q2 2025 | 129 | $2.77B |
| Q1 2025 | 135 | $2.33B |
| Q4 2024 | 115 | $3.42B |
| Q3 2024 | 108 | $3.13B |
| Q2 2024 | 110 | $2.67B |
| Q1 2024 | 113 | $2.98B |
| Q4 2023 | 125 | $3.53B |
| Q3 2023 | 118 | $3.21B |
| Q2 2023 | 83 | $2.86B |
| Q1 2023 | 43 | $843.2M |
| Q4 2022 | 33 | $396.4M |
| Q3 2022 | 24 | $291.4M |
| Q2 2022 | 23 | $190.1M |
| Q1 2022 | 1 | $7.26M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding MoonLake Immunotherapeutics; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BVF Inc | 21,751,284 | $114.2M | 5.51% | +21,751,284 | New |
| Cormorant Asset Management, LP | 6,065,001 | $30.9M | 2.40% | +2,785,001+84.9% | Added |
| Citadel Advisors LLC | 2,702,661 | $13.9M | 0.02% | +2,003,765+286.7% | Added |
| FMR LLC | 1,193,290 | $6.26M | 0.00% | +2900.0% | Added |
| TCG Crossover Management, LLC | 1,000,000 | $5.25M | 2.23% | +1,000,000 | New |
| Price T Rowe Associates Inc | 870,524 | $4.44M | 0.00% | +304,333+53.8% | Added |
| BlackRock Inc. | 741,906 | $3.90M | 0.00% | 00.0% | Unchanged |
| RTW Investments, LP | 500,000 | $2.63M | 0.07% | +500,000 | New |
| Great Point Partners LLC | 432,000 | $2.27M | 0.58% | +432,000 | New |
| Tang Capital Management LLC | 319,043 | $1.68M | 0.25% | +319,043 | New |
| Ghost Tree Capital, LLC | 300,000 | $1.57M | 1.08% | +300,000 | New |
| Monashee Investment Management LLC | 200,000 | $1.05M | 0.38% | +200,000 | New |
| Citigroup Inc | 159,087 | $835.0K | 0.00% | +159,087 | New |
| UBS Group AG | 73,660 | $387.0K | 0.00% | +71,968+4,253.4% | Added |
| Alps Advisors Inc | 31,260 | $164.0K | 0.00% | +31,260 | New |
| TD Asset Management Inc | 28,966 | $152.0K | 0.00% | +28,966 | New |
| Millennium Management LLC | 28,090 | $147.0K | 0.00% | −120,135−81.0% | Reduced |
| Meridian Wealth Management, LLC | 27,000 | $142.0K | 0.01% | −15,094−35.9% | Reduced |
| Cowen and Company, LLC | 16,173 | $85.0K | 0.01% | +16,173 | New |
| Barclays PLC | 15,083 | $79.0K | 0.00% | +15,083 | New |
| Goldman Sachs Group Inc | 11,785 | $62.0K | 0.00% | +11,785 | New |
| Penserra Capital Management LLC | 3,195 | $16.0K | 0.00% | +3,195 | New |
| Tower Research Capital LLC (TRC) | 25 | $0 | 0.00% | +25 | New |
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −790,000−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −653,872−100.0% | Sold out |
| Staley Capital Advisers Inc | 0 | $0 | 0.00% | −580,000−100.0% | Sold out |
| Beryl Capital Management LLC | 0 | $0 | 0.00% | −459,243−100.0% | Sold out |
| Falcon Edge Capital, LP | 0 | $0 | 0.00% | −448,882−100.0% | Sold out |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −400,000−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −337,021−100.0% | Sold out |
| Tekla Capital Management LLC | 0 | $0 | 0.00% | −250,000−100.0% | Sold out |
| EcoR1 Capital, LLC | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Weiss Asset Management LP | 0 | $0 | 0.00% | −177,510−100.0% | Sold out |
| Iron Park Capital Partners, LP | 0 | $0 | 0.00% | −179,434−100.0% | Sold out |
| Consonance Capital Management LP | 0 | $0 | 0.00% | −137,000−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −65,437−100.0% | Sold out |
| Picton Mahoney Asset Management | 0 | $0 | 0.00% | −70,000−100.0% | Sold out |
| Fir Tree Capital Management LP | 0 | $0 | 0.00% | −61,866−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −46,247−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −22,733−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −14,613−100.0% | Sold out |
| Clear Street LLC | 0 | $0 | 0.00% | −801−100.0% | Sold out |